JP2010505850A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010505850A5 JP2010505850A5 JP2009531472A JP2009531472A JP2010505850A5 JP 2010505850 A5 JP2010505850 A5 JP 2010505850A5 JP 2009531472 A JP2009531472 A JP 2009531472A JP 2009531472 A JP2009531472 A JP 2009531472A JP 2010505850 A5 JP2010505850 A5 JP 2010505850A5
- Authority
- JP
- Japan
- Prior art keywords
- taxane
- pharmaceutical composition
- recombinant mva
- antigen
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85003106P | 2006-10-06 | 2006-10-06 | |
| US60/850,031 | 2006-10-06 | ||
| PCT/US2007/021436 WO2008045346A2 (en) | 2006-10-06 | 2007-10-05 | Recombinant modified vaccinia ankara encoding a her-2 antigen for use in treating cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014047741A Division JP6124822B2 (ja) | 2006-10-06 | 2014-03-11 | Ｍｖａを使ってがんを処置する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010505850A JP2010505850A (ja) | 2010-02-25 |
| JP2010505850A5 true JP2010505850A5 (enExample) | 2010-08-19 |
| JP5964540B2 JP5964540B2 (ja) | 2016-08-03 |
Family
ID=39283388
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009531472A Active JP5964540B2 (ja) | 2006-10-06 | 2007-10-05 | Ｍｖａを使ってがんを処置する方法 |
| JP2014047741A Active JP6124822B2 (ja) | 2006-10-06 | 2014-03-11 | Ｍｖａを使ってがんを処置する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014047741A Active JP6124822B2 (ja) | 2006-10-06 | 2014-03-11 | Ｍｖａを使ってがんを処置する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7807146B2 (enExample) |
| EP (2) | EP2073837B1 (enExample) |
| JP (2) | JP5964540B2 (enExample) |
| AU (1) | AU2007307080B2 (enExample) |
| CA (1) | CA2665068C (enExample) |
| DK (2) | DK2596801T3 (enExample) |
| ES (1) | ES2500465T3 (enExample) |
| IL (1) | IL197633A (enExample) |
| NZ (2) | NZ575388A (enExample) |
| PT (1) | PT2073837E (enExample) |
| WO (1) | WO2008045346A2 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002042480A2 (en) * | 2000-11-23 | 2002-05-30 | Bavarian Nordic A/S | Modified vaccinia ankara virus variant |
| NZ575388A (en) * | 2006-10-06 | 2012-03-30 | Bn Immunotherapeutics Inc | Recombinant modified vaccinia ankara encoding a her-2 antigen and a taxane for use in treating cancer |
| US20110206736A1 (en) * | 2008-09-23 | 2011-08-25 | Thomas Jefferson University | Cancer Vaccines Against Mucosal Antigens and Methods of Making and Using the Same |
| WO2012059376A1 (en) * | 2010-11-02 | 2012-05-10 | Telefonaktiebolaget L M Ericsson (Publ) | Methods and devices for media description delivery |
| US9463238B2 (en) | 2011-12-09 | 2016-10-11 | Bavarian Nordic A/S | Recombinant poxvirus vector comprising tetanus toxin fragment C |
| DK2788021T3 (en) | 2011-12-09 | 2017-04-10 | Bavarian Nordic As | POXVIRUS VECTOR FOR EXPRESSION OF BACTERIAL ANTIGENES CONNECTED TO TETANANOX INFRAGMENT C |
| CA2888367A1 (en) * | 2012-10-19 | 2014-04-24 | Bavarian Nordic, Inc. | Methods and compositions for the treatment of cancer |
| EP2777711A1 (en) * | 2013-03-11 | 2014-09-17 | Icon Genetics GmbH | Her2/Neu cancer vaccine |
| JP6444398B2 (ja) | 2013-07-03 | 2018-12-26 | コニンクリーケ・ケイピーエヌ・ナムローゼ・フェンノートシャップ | セグメント化コンテンツのストリーミング |
| AU2014340201B2 (en) | 2013-10-23 | 2019-02-21 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use |
| US10639366B2 (en) | 2015-02-25 | 2020-05-05 | Memorial Sloan Kettering Cancer Center | Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors |
| KR20180006916A (ko) | 2015-04-17 | 2018-01-19 | 메모리얼 슬로안-케터링 캔서 센터 | 고형 종양에 대한 면역치료제로서 mva 또는 mva델타e3l의 용도 |
| FR3042121A1 (fr) | 2015-10-08 | 2017-04-14 | Jean-Marc Limacher | Composition anti-tumorale |
| KR20180130500A (ko) | 2016-02-25 | 2018-12-07 | 메모리얼 슬로안 케터링 캔서 센터 | 인간 flt3l을 발현하는 재조합 mva 또는 mvaδe3l 및 고형 종양에 대한 면역요법제로서 그의 용도 |
| AU2017222686B2 (en) | 2016-02-25 | 2021-12-23 | Memorial Sloan Kettering Cancer Center | Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy |
| EP3621646A4 (en) | 2017-05-12 | 2021-06-02 | Memorial Sloan Kettering Cancer Center | VACCINIA VIRUS MUTANTS FOR CANCER IMMUNOTHERAPY |
| CA3061678A1 (en) | 2017-05-15 | 2018-11-22 | Janssen Vaccines & Prevention B.V. | Stable virus-containing composition |
| KR102658198B1 (ko) | 2017-05-15 | 2024-04-16 | 얀센 백신스 앤드 프리벤션 비.브이. | 안정한 바이러스 함유 조성물 |
| WO2019090343A1 (en) * | 2017-11-06 | 2019-05-09 | Memorial Sloan Kettering Cancer Center | Heat-inactivated vaccinia virus as a vaccine immune adjuvant |
| CN116162654A (zh) | 2018-09-15 | 2023-05-26 | 纪念斯隆凯特琳癌症中心 | 用于癌症免疫疗法的重组痘病毒 |
| TWI852977B (zh) | 2019-01-10 | 2024-08-21 | 美商健生生物科技公司 | 前列腺新抗原及其用途 |
| AU2020385683A1 (en) | 2019-11-18 | 2022-06-30 | Janssen Biotech, Inc. | Vaccines based on mutant CALR and JAK2 and their uses |
| WO2022009052A2 (en) | 2020-07-06 | 2022-01-13 | Janssen Biotech, Inc. | Prostate neoantigens and their uses |
| FR3160186A1 (fr) | 2024-03-13 | 2025-09-19 | Odimma Therapeutics | Vecteur non-viral pour transcription augmentee |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1341245C (en) | 1988-01-12 | 2001-06-05 | F. Hoffmann-La Roche Ag | Recombinant vaccinia virus mva |
| DK96493D0 (da) | 1993-08-26 | 1993-08-26 | Mouritsen Og Elsner Aps | Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden |
| PT735893E (pt) | 1993-09-14 | 2009-03-06 | Pharmexa Inc | Péptidos que se ligam aos alelos pan dr para aumentar a resposta imunitária |
| US6326356B1 (en) * | 1996-10-18 | 2001-12-04 | Board Of Regents, The University Of Texas System | Suppression of neu overexpression using a mini-E1A gene |
| UA68327C2 (en) | 1995-07-04 | 2004-08-16 | Gsf Forschungszentrum Fur Unwe | A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals |
| AUPO390396A0 (en) | 1996-11-29 | 1996-12-19 | Csl Limited | Novel promiscuous T helper cell epitopes |
| DE19729279A1 (de) | 1997-07-09 | 1999-01-14 | Peter Hildebrandt | Urologisches Implantat, insbesondere Gefäßwandstütze für den Urinaltrakt |
| KR100731820B1 (ko) | 1998-10-05 | 2007-06-25 | 파멕사 에이/에스 | 치료적 백신화를 위한 새로운 방법 |
| DE10042598A1 (de) | 2000-08-30 | 2002-03-28 | Gsf Forschungszentrum Umwelt | Rekombinantes MVA mit der Fähigkeit zur Expression des HER-2/Neu-GENS |
| WO2002042480A2 (en) | 2000-11-23 | 2002-05-30 | Bavarian Nordic A/S | Modified vaccinia ankara virus variant |
| JP2005508323A (ja) * | 2001-09-26 | 2005-03-31 | インターミューン インコーポレイテッド | 癌治療のための医薬組成物及び方法 |
| AU2003276467A1 (en) * | 2002-11-06 | 2004-06-07 | Cyclacel Limited | Combination comprising docetaxel and a cdk inhibitor |
| EP1575601B1 (en) | 2002-12-16 | 2015-07-01 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Recombinant vaccine viruses expressing il-15 and methods of using the same |
| CN1511549A (zh) * | 2002-12-27 | 2004-07-14 | 张小丽 | 含有黄芩的抗肿瘤、抗炎症及肿瘤预防药物的组合物 |
| ITMI20030317A1 (it) * | 2003-02-21 | 2004-08-22 | Pharmacia Italia Spa | Terapia combinata comprendente un derivato dell'indolopirrolocarbazolo ed un altro agente antitumorale. |
| US20040197312A1 (en) * | 2003-04-02 | 2004-10-07 | Marina Moskalenko | Cytokine-expressing cellular vaccine combinations |
| CA2526212C (en) * | 2003-05-16 | 2013-08-27 | Hybridon, Inc. | Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents |
| MXPA05013389A (es) * | 2003-06-25 | 2006-03-17 | Pharmexa As | Purificacion de variantes her-2. |
| KR20060033870A (ko) * | 2003-06-25 | 2006-04-20 | 파멕사 에이/에스 | Ｈｅｒ-2 변이체의 정제 |
| US7951780B2 (en) * | 2004-02-25 | 2011-05-31 | Astellas Pharma Inc. | Antitumor agent |
| DK1855720T4 (da) | 2005-02-23 | 2023-07-24 | Bavarian Nordic As | Anvendelse af et modificeret poxvirus til hurtig induktion af immunitet mod et poxvirus eller andre smitstoffer |
| NZ575388A (en) * | 2006-10-06 | 2012-03-30 | Bn Immunotherapeutics Inc | Recombinant modified vaccinia ankara encoding a her-2 antigen and a taxane for use in treating cancer |
-
2007
- 2007-10-05 NZ NZ575388A patent/NZ575388A/en unknown
- 2007-10-05 DK DK13154196.3T patent/DK2596801T3/en active
- 2007-10-05 DK DK07839307.1T patent/DK2073837T3/da active
- 2007-10-05 WO PCT/US2007/021436 patent/WO2008045346A2/en not_active Ceased
- 2007-10-05 EP EP07839307.1A patent/EP2073837B1/en active Active
- 2007-10-05 AU AU2007307080A patent/AU2007307080B2/en active Active
- 2007-10-05 NZ NZ597998A patent/NZ597998A/xx unknown
- 2007-10-05 EP EP13154196.3A patent/EP2596801B1/en active Active
- 2007-10-05 ES ES07839307.1T patent/ES2500465T3/es active Active
- 2007-10-05 PT PT78393071T patent/PT2073837E/pt unknown
- 2007-10-05 JP JP2009531472A patent/JP5964540B2/ja active Active
- 2007-10-05 US US11/905,876 patent/US7807146B2/en active Active
- 2007-10-05 CA CA2665068A patent/CA2665068C/en active Active
-
2009
- 2009-03-17 IL IL197633A patent/IL197633A/en active IP Right Grant
-
2010
- 2010-08-31 US US12/872,156 patent/US8313740B2/en active Active
-
2014
- 2014-03-11 JP JP2014047741A patent/JP6124822B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010505850A5 (enExample) | ||
| NZ604029A (en) | Methods of treating bladder cancer | |
| RU2009121568A (ru) | Комбинации и способы введения терапевтических агентов и комбинированная терапия | |
| RU2012106620A (ru) | Комбинации и способы введения терапевтических средств и комбинированной терапии | |
| NZ707377A (en) | Combination therapy methods for treating proliferative diseases | |
| JP2013541583A5 (enExample) | ||
| JP2009513662A5 (enExample) | ||
| JP2012522837A5 (enExample) | ||
| RU2010132581A (ru) | Способы терапии заболеваний легких | |
| EA200800663A1 (ru) | Способ и средство профилактики и лечения нарушенного дыхания во время сна | |
| JP2015532293A5 (ja) | 糖尿病患者における心不全の治療用組成物 | |
| JP2015522603A5 (enExample) | ||
| WO2005089448A3 (en) | Administration of cisplatin by inhalation | |
| JP2013544892A5 (enExample) | ||
| JP2008534503A5 (enExample) | ||
| JP2010500284A5 (enExample) | ||
| CN101905006A (zh) | 一种治疗跌打损伤外用药 | |
| CN101049337A (zh) | 一种治疗疔疖疮痈的药物及其制备方法 | |
| JP2015510945A5 (enExample) | ||
| JP2011500650A5 (enExample) | ||
| MX2010006310A (es) | O-desmetil-venlafaxina para el tratamiento de transtorno depresivo mayor. | |
| CN104606655A (zh) | 一种用于铺灸治疗风寒湿痹症的蒜姜组合物及其应用 | |
| RU2013148539A (ru) | Алиспоривир для лечения инфекции вируса гепатита с | |
| JP2010521488A5 (enExample) | ||
| CN202044647U (zh) | 治疗甲状腺病的护脖 |